Effects of Formulary Tools on Slowing Opioid Consumption

Drug formularies are potentially valuable tools to manage and improve prescription opioid use and overdose prevention. Through a grant with the CDC , Drs. Cochran and Donohue lead a project to evaluate patterns of problematic opioid consumption and overdose in Medicaid, and test the effects of formulary tools on slowing or reducing problematic opioid consumption and overdose.  Read more

Pennsylvania PDMP Provider Education

Cp3 and affiliated faculty are helping the state of Pennsylvania develop educational materials and programs to increase utilization of the state's new prescription drug monitoring program. Read more

VA Randomized Program Evaluation

Dr. Gellad is co-leading a qualitative evaluation of the randomized roll out across VA facilities of a tool that predicts the risk of opioid overdose or suicide related events among Veterans receiving opioid medications.  Read more

De-Intensifying Unnecessary Medications in VA CLC Residents Nearing End of Life

Funding Period May 2016 - July 2019
This project, funded by a VA Health Services Research and Development (HSR&D) Merit Award, will examine determinants and outcomes of intense vs. de-intensified treatment of common chronic conditions in VA nursing home residents with limited life expectancy or advanced dementia. Read more

Opioid Medication Use in the Veteran Population

In 2015, Dr. Gellad received a three year grant from the US Department of Veterans Affairs to study opioid use in the veteran population, specifically those receiving care from multiple health systems.  Read more

Safety Implications of patients with Dementia Receiving Prescription Drugs

Expanding veterans' access to providers outside of the VA may increase the risk for unsafe prescribing practices, particularly in persons with dementia.  Read more

Use of Buprenorphine in Pennsylvania State Medicaid Programs

The use of buprenorphine - an effective treatment for opioid use disorders (OUDs) - has increased rapidly in recent years and is often financed by Medicaid. CP3 and MRC researchers investigated.    Read more